SCHEMBL4084190

SCHEMBL4084190

C[Si](C)(C)c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5ccccc5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 1/20 0.42
▸ ESR1 P03372 4/20 0.42
▸ ESR2 Q92731 3/20 0.42
▸ CYP1A2 P05177 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ LPL P06858 1/20 0.40
▸ LIPG Q9Y5X9 1/20 0.40
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ GPR84 Q9NQS5 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ HTR5A P47898 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13007010 0.94 ESR1 (0.41) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL125705 0.94 ESR1 (0.43) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL124687 0.94 ESR1 (0.43) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL20110000 0.92 HSD17B1 (0.44) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL14340316 0.92 ESR1 (0.43) ESR1ESR2CYP1A2SMN1; SMN2ALDH1A1
SCHEMBL16805209 0.91 ESR1 (0.41) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL126430 0.90 ESR1 (0.42) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL13995125 0.89 ESR1 (0.42) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL16352618 0.89 IKBKB (0.41) IKBKBESR1ESR2CYP1A2SMN1; SMN2
SCHEMBL125736 0.89 ESR1 (0.42) IKBKBESR1ESR2CYP1A2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11189809-B2 Organic EL device and display unit SONY CORPORATION (JP) 2021-11-30 — — US disclosed
US-20170271609-A1 ORGANIC EL DEVICE AND DISPLAY UNIT SONY CORPORATION (JP) 2017-09-21 — — US disclosed
US-20170271609-A1 ORGANIC EL DEVICE AND DISPLAY UNIT SONY CORPORATION (JP) 2017-09-21 — — US disclosed
US-9024301-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2015-05-05 — — US disclosed
US-9024301-B2 Organic luminescent medium and organic EL device IDEMITSU KOSAN CO., LTD. (JP) 2015-05-05 — — US disclosed
US-8586202-B2 Organic electroluminescent device and display device SONY CORPORATION (JP) 2013-11-19 — — US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-8530062-B2 Organic electroluminescent element and display SONY CORPORATION (JP) 2013-09-10 — — US disclosed
US-20130221338-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 — — US disclosed
US-20130221338-A1 ORGANIC LUMINESCENT MEDIUM AND ORGANIC EL DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2013-08-29 — — US disclosed
US-7887931-B2 comprises an anode and a cathode and located there-between a light emitting layer containing a light emitting dopant and a host comprising a monoanthracene derivative; improved operational stability GLOBAL OLED TECHNOLOGY LLC (US) 2011-02-15 — — US disclosed
US-20110024736-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY SONY CORPORATION (JP) 2011-02-03 — — US disclosed
US-20100253214-A1 ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY DEVICE SONY CORPORATION (JP) 2010-10-07 — — US disclosed
US-7471041-B2 OLED multicolor displays EASTMAN KODAK COMPANY (US) 2008-12-30 — — US disclosed
US-7471041-B2 OLED multicolor displays EASTMAN KODAK COMPANY (US) 2008-12-30 — — US disclosed
US-7439670-B2 Making multicolor OLED displays EASTMAN KODAK COMPANY (US) 2008-10-21 — — US disclosed
US-7436113-B2 Multicolor OLED displays EASTMAN KODAK COMPANY (US) 2008-10-14 — — US disclosed
US-20080093989-A1 SELECTING WHITE POINT FOR OLED DEVICES GLOBAL OLED TECHNOLOGY LLC 2008-04-24 — — US disclosed
US-20080093989-A1 SELECTING WHITE POINT FOR OLED DEVICES GLOBAL OLED TECHNOLOGY LLC 2008-04-24 — — US disclosed
US-7252893-B2 Anthracene derivative host having ranges of dopants EASTMAN KODAK COMPANY (US) 2007-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11189809-B2 Organic EL device and display unit L1CAM, ESR1, EPHA8 IKBKB 2787/4885ESR1 2/4885ESR2 47/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback